OpportunityTitle: Expanding and Personalizing Treatment Options for Alcohol Use Disorders Including Pharmacogenomics (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: Purpose. Under this Funding Opportunity Announcement (FOA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA) requests research project grants (R01) to study how genetic variation affects responses to medications for the treatment of Alcohol Use Disorders (AUD). Both human and animal studies are encouraged to determine the full range of genetic variation affecting both pharmacodynamic and pharmacokinetic parameters resulting in altered drug efficacy and toxicity. Mechanistic studies using animal models and/or in vitro/ex vivo preparations are also encouraged. Mechanism of Support. This FOA will utilize the R01 grant mechanism. Funds Available and Anticipated Number of Awards. NIAAA has available $2 million in total cost for fiscal year 2011 for this announcement and expects that two to four awards will be made.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;